WHO’s fight against resistance to artemisinin faces uphill struggle.

Five months ago the World Health Organization (WHO) called for a voluntary ban on the distribution of the antimalarial drug artemisinin on its own as opposed to in a combination treatment. But only one-third of the 40 targeted pharmaceutical companies have agreed to comply, with others remaining silent on the issue.

Read the story here.